BioLargo, Inc.
BLGO
$0.2365
$0.00351.50%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.66M | 4.35M | 5.01M | 4.76M | 4.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.66M | 4.35M | 5.01M | 4.76M | 4.37M |
| Cost of Revenue | 1.91M | 2.63M | 2.88M | 2.51M | 2.28M |
| Gross Profit | 1.75M | 1.72M | 2.14M | 2.25M | 2.09M |
| SG&A Expenses | 2.58M | 2.09M | 2.40M | 2.23M | 2.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -1.00K |
| Total Operating Expenses | 5.27M | 5.41M | 5.90M | 5.52M | 4.98M |
| Operating Income | -1.62M | -1.06M | -890.00K | -763.00K | -611.00K |
| Income Before Tax | -1.73M | -1.06M | -780.00K | -775.00K | -1.02M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.73M | -1.06M | -780.00K | -775.00K | -1.02M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 718.00K | 523.00K | 339.00K | 365.00K | 291.00K |
| Net Income | -1.01M | -537.00K | -441.00K | -410.00K | -729.00K |
| EBIT | -1.62M | -1.06M | -890.00K | -763.00K | -611.00K |
| EBITDA | -1.58M | -1.02M | -854.00K | -727.00K | -602.00K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 301.22M | 300.49M | 296.44M | 294.31M | 290.15M |
| Average Diluted Shares Outstanding | 301.22M | 300.49M | 296.44M | 294.31M | 290.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |